Psychol Med. 1990 Nov;20(4):843-8.

Subjective utility ratings of neuroleptics in treating schizophrenia.

Finn SE, Bailey JM, Schultz RT, Faber R.

Source

Department of Psychology, University of Texas, Austin 78712.

Abstract

This study developed a method for measuring subjective costs and benefits of psychiatric treatments. Forty-one patients rates the relative bothersomeness of symptoms of schizophrenia and side effects of neuroleptics. Thirty-four psychiatrists made parallel ratings from the perspective of the average patient (individual utility) and of the patient's family and society (institutional utility). Psychiatrists predicted patients' ratings moderately well, but misjudged the bothersomeness to patients of 24% of side effects and 20% of symptoms. When considering the patient's perspective, both schizophrenic patients and psychiatrists rated symptoms as no more bothersome than side effects. However, psychiatrists saw side effects as significantly less bothersome than symptoms when considering costs to society. The subjective utility of neuroleptic medications for schizophrenia is most justifiable from an institutional perspective.

PMID:: 1980954; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Antipsychotic Agents

LinkOut - more resources

Medical

Schizophrenia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects. [Prog Neuropsychopharmacol Biol...]
Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.
Taira M, Hashimoto T, Takamatsu T, Maeda K. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30; 30(6):1139-42. Epub 2006 Jun 12.
Subjective response to neuroleptics in schizophrenia. [Schizophr Bull. 1993]
Subjective response to neuroleptics in schizophrenia.
Awad AG. Schizophr Bull. 1993; 19(3):609-18.
[Psychological effects of previous treatment experiences with neuroleptics]. [Nervenarzt. 1990]
[Psychological effects of previous treatment experiences with neuroleptics].
Bossert S, Dose M, Emrich HM, Garcia D, Junker M, Raptis K, Weber MM. Nervenarzt. 1990 May; 61(5):301-5.
Review [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. [Encephale. 2005]
Review [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, et al. Encephale. 2005 Mar-Apr; 31(2):235-46.
Review [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]. [Psychiatr Prax. 2004]
Review [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D, Lambert M, Karow A. Psychiatr Prax. 2004 Nov; 31 Suppl 2:S230-2.

See reviews... See all...

Cited by 1 PubMed Central article

The side effects of antipsychotic drugs and patients' quality of life: patient education and preference assessment with computers and multimedia. [Proc Annu Symp Comput Appl Med...]
The side effects of antipsychotic drugs and patients' quality of life: patient education and preference assessment with computers and multimedia.
Morss SE, Lenert LA, Faustman WO. Proc Annu Symp Comput Appl Med Care. 1993; :17-21.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Subjective utility ratings of neuroleptics in treating schizophrenia.
Subjective utility ratings of neuroleptics in treating schizophrenia.
Psychol Med. 1990 Nov ;20(4):843-8.

PubMed
A Cognitive Neuroscience View of Schizophrenic Symptoms: Abnormal Activation of ...
A Cognitive Neuroscience View of Schizophrenic Symptoms: Abnormal Activation of a System for Social Perception and Communication.
Brain Imaging Behav. 2009 Mar 1;3(1):85-110.

PubMed
Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitu...
Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychol Med. 1990 Nov ;20(4):835-42.

PubMed
High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas...
High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome.
Mol Med. 2010 Jan-Feb ;16(1-2):1-9. Epub 2009 Oct 12 .

PubMed
Comprehensive expression analysis of FSHD candidate genes at the mRNA and protei...
Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.
Eur J Hum Genet. 2009 Dec ;17(12):1615-24. Epub 2009 Oct 7 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: